SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001657312-23-000008
Filing Date
2023-05-09
Accepted
2023-05-09 06:13:29
Documents
14
Period of Report
2023-05-09
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K vrna-20230509.htm   iXBRL 8-K 47536
2 EX-99.1 vrnaq12023pressrelease.htm EX-99.1 57139
6 GRAPHIC image_0.jpg GRAPHIC 111995
  Complete submission text file 0001657312-23-000008.txt   408459

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20230509.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20230509_lab.xml EX-101.LAB 24633
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20230509_pre.xml EX-101.PRE 12986
8 EXTRACTED XBRL INSTANCE DOCUMENT vrna-20230509_htm.xml XML 11221
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 23899793
SIC: 2834 Pharmaceutical Preparations